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OBJECTIVES The purpose of this study was to compare color-flow duplex imaging (CFDI), intravascular
ultrasound (IVUS), and renal arteriography in diagnosing renal artery (RA) fibromuscular
dysplasia (FMD) and correlating with the hemodynamic response to balloon angioplasty
(BA) in patients with drug-resistant hypertension.
BACKGROUND Renal arteriography is generally regarded as the gold standard for diagnosing RA FMD. The
observation that CFDI and IVUS depicted endoluminal abnormalities suggestive of RA
FMD in some patients with normal renal arteriograms prompted comparison of these
modalities in a consecutive series of patients.
METHODS Twenty hypertensive patients with CFDI suggestive of RA FMD (mid-to-distal flow
derangement and velocity augmentation) underwent renal arteriography, IVUS, and BA, with
both immediate and long-term blood pressure (BP) response assessment.
RESULTS All patients were women, aged 31 to 86 years (mean 62 years). On IVUS, various
endoluminal defects (eccentric ridges; fluttering membranes; spiraling folds) were depicted at
locations predicted by CFDI and were uniformly identified at sites where arteriography
depicted classic evidence of FMD (8 patients). However, similar defects were detected by
IVUS when angiography was borderline (7 patients) or normal (5 patients). Balloon
angioplasty eliminated (16 patients) or reduced (4 patients) the IVUS findings and lowered
systolic BP in all (mean reduction 53 mm Hg, p  0.0001). This reduction was maintained
during follow-up of 4 to 22 (mean 13) months (mean reduction 44 mm Hg, p  0.0001),
independent of baseline angiographic appearance.
CONCLUSIONS Both CFDI and IVUS depict the blood flow and endoluminal abnormalities of RA FMD.
Balloon angioplasty eliminates or improves IVUS findings and produces substantial, sustained
BP reduction, an effect that is independent of baseline arteriographic appearance, calling into
question the legitimacy of arteriography as the diagnostic gold standard. (J Am Coll Cardiol
2003;41:1305–11) © 2003 by the American College of Cardiology Foundation
Renal artery (RA) stenosis is an important cause or com-
ponent of hypertension and can be a major factor contrib-
uting to renal insufficiency and failure. A number of factors,
including growing availability of therapeutic options, in-
creasing awareness, and the evolution of reliable noninvasive
diagnostic tools, have led to an increase in screening for this
See page 1312
diagnosis. Included among these noninvasive tests is color-
flow duplex imaging (CFDI), which can depict high flow
velocities, kidney size, anomalous RA origin, the presence of
accessory RAs, renal cysts and masses, and the incidental
presence of an abdominal aortic aneurysm (1). In addition,
CFDI can indicate whether RA obstruction is localized to
the ostial/proximal arterial segment (typical of atheroscle-
rosis) or in the middle or distal segments (the distribution
more typical of other causes, most commonly fibromuscular
dysplasia [FMD]). Several patients with severe, drug-
resistant hypertension were found to have CFDI abnormal-
ities that, by their mid-to-distal location, suggested renal
artery FMD, but subsequent renal angiography demon-
strated normal or nearly normal RAs, rather than the classic
beaded appearance typical of this disorder (2,3). Intravas-
cular ultrasound (IVUS) is a method for detecting endolu-
minal and arterial wall anatomy which can be underesti-
mated or even completely inapparent on angiography.
Therefore, in an attempt to explain the CFDI abnormalities
in hypertensive patients whose renal arteriograms were not
classically abnormal, a consecutive series of patients with
CFDI evidence of RA flow derangements suggestive of RA
FMD and who underwent subsequent renal arteriography
were also studied with RA IVUS, and the impact of balloon
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angioplasty (BA) on IVUS findings and blood pressure (BP)
was assessed.
METHODS
From January 1998 to April 2000, twenty patients being
screened for RA stenosis because of uncontrolled, drug-
resistant, or new-onset hypertension were found by nonin-
vasive ultrasound evaluation (CFDI) of their RAs to have
abnormalities suggesting FMD. These abnormalities in-
cluded high flow velocity, high flow velocity ratio relative to
adjacent aortic flow velocity, and abnormal, nonlaminar
flow patterns (such as aliasing and spiraling flow) localized
to the middle and/or distal segments of the affected RA. All
CFDI was performed in an ICAVL (Intersocietal Commis-
sion for Accreditation of Vascular Laboratories)-certified
laboratory by certified vascular sonographers using a curvi-
linear C5-2 MHz imaging probe as part of the HDI 5000
(Advanced Technology Laboratories, Bothell, Washington)
cardiovascular ultrasound machine. Patients were imaged in
the supine position with an average study time of about 40
min. Whereas, in the past, bowel gas or obesity would
occasionally interfere with such an examination, newer
imaging apparatus and the ability to image from multiple
sonographic windows have nearly eliminated this obstacle to
obtaining diagnostic studies. No patients undergoing RA
ultrasound evaluation during the time course of patient
acquisition in this series failed to have fully diagnostic
studies, either because of bowel gas or body habitus.
Routine evaluation included the following: 1) long and
transverse views of the aorta with recording of peak mid-
systolic blood flow velocity, and 2) two-dimensional views
with color-flow and spectral Doppler interrogation of the
origin, proximal, middle, and distal segments of the RA.
Peak systolic velocities 200 cm/s and RA:aorta systolic
flow velocity ratio 2.0 were the flow velocity criteria
utilized to indicate hemodynamically significant FMD. In
our laboratory, diastolic blood flow velocities have not been
found to be helpful in evaluating these patients and were not
utilized in this analysis. In general, however, greater weight
was given to the qualitative appearance of blood flow
derangement than to these numerical criteria.
Subsequently, these patients underwent selective renal
arteriography with 6F internal mammary artery diagnostic
catheters via a transfemoral approach. Contrast medium
(Omnipaque) was injected selectively into each RA at the
rate of 4 ml/s for 10 cc volume. Each RA was imaged in the
standard anterior-posterior projection as well as the 10° to
20° right anterior oblique projection for the right RA and 10
to 20° left anterior oblique projection for the left RA,
respectively, to minimize overlap of branches and to view
the ostium clearly, without overlap of the adjacent aorta. In
some patients, cranial and caudal angulations were also used
when required to fully assess the arteriographic anatomy.
Images were obtained with an Integris X-ray system (Phil-
ips, Eindhoven, Holland) on 35-mm film at 15 frames/s and
also stored in a digital archive. The arteriograms were
reviewed by three cardiologists and assigned to one of three
descriptive categories.
The first category (abnormal) was defined by the presence
of classic arteriographic findings of FMD, namely a beaded
appearance produced by multiple, eccentric, cleft-like ste-
noses appearing beyond the most proximal segment of the
RA. The second category (normal) comprised those arte-
riograms with no evidence of FMD or other stenosis or
luminal irregularity. The third category (borderline) was
intermediate between these two and consisted of those
angiograms that did not show the classic findings of FMD
but were not entirely normal, such as mild luminal narrow-
ing or mild scalloping of the lumen edge. Differences among
interpreters (which were infrequent) were resolved by con-
sensus. A specific evaluation of intraobserver variability was
not undertaken. Inasmuch as all patients were included in
this analysis on the basis of abnormal CFDI, none of the
three angiographic interpreters were blinded to the general
nature of the noninvasive test results, but the specific
findings were not available at the time of arteriographic
characterization.
All patients in this series underwent IVUS examination
to assess for the presence of endoluminal abnormalities. All
imaging was performed by the interventional cardiologist at
the time of arteriography and angioplasty using a 3.2F
20-MHz Sonicath IVUS imaging catheter (Boston
Scientific/Medi-Tech, Natick, Massachusetts). The IVUS
findings were correlated with angiography and CFDI re-
sults. All patients then underwent balloon angioplasty at
sites indicated by these imaging methods. In all cases,
noncompliant balloon catheters (UltraThin Diamond, Bos-
ton Scientific/Medi-Tech) were used, the diameter chosen to
exceed the normal reference segment by 0.5 to 1 mm. These
balloon catheters were introduced into the artery through an
8F guiding catheter (Medtronic PK1 Renal Guide Catheter),
and correct positioning of the balloon catheter was assessed by
injection of contrast from the guide catheter.
Following balloon dilation, IVUS and angiography were
repeated to evaluate the impact of the angioplasty procedure
on the ultrasound and arteriographic findings. Blood pres-
sure was monitored over the next 12 to 24 h, and antihy-
pertensive agents were revised, when appropriate, based on
BP response before discharge from the hospital. Both BP
and antihypertensive therapy were monitored over a
follow-up interval ranging up to 22 months. Overnight and
Abbreviations and Acronyms
BA  balloon angioplasty
BP  blood pressure
CFDI  color-flow duplex imaging
CT  computed tomography/tomographic
FMD  fibromuscular dysplasia
IVUS  intravascular ultrasound
MRA  magnetic resonance angiography
RA  renal artery
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long-term group and individual BP responses were assessed
using the Student t test and chi-square methods.
RESULTS
Data were reviewed on 20 consecutive patients being eval-
uated for drug-resistant or new-onset hypertension and
having abnormal CFDI RA blood flow suggestive of FMD.
All were women. Ages ranged from 31 to 86 years (mean 62
years). In the outpatient evaluation of these patients prior to
angioplasty, systolic BP ranged from 138 to 240 mm Hg
(mean 178  28 mm Hg). In all patients, the directly
measured BP recorded at the time of the invasive procedure
equaled or exceeded these outpatient BP recordings. Base-
line creatinine level was normal (1.5 mg/dl) in all patients.
Before angioplasty, all patients were being treated with at
least two (mean 2.6) antihypertensive medications (alpha-
blockers, beta-blockers, calcium channel blockers,
angiotensin-converting enzyme [ACE] inhibitors, angio-
tensin receptor blockers, diuretics, and nitrates) (Table 1).
Patients were selected for invasive evaluation and treat-
ment on the basis of abnormal CFDI suggestive of FMD.
The flow abnormalities were localized to the middle seg-
ment of the artery in 14 patients and in the middle and
distal segment of the artery in 6. Abnormalities were
unilateral in 8 patients and bilateral in 12, consisting of
abnormal, nonlaminar flow patterns including aliasing and
spiraling flow as depicted by the color-flow pattern. These
color-flow abnormalities were supplemented by spectral
Doppler flow-velocity derangements indicative of RA ob-
struction, including augmentation of flow velocity at the site
of disturbed flow on CFDI (1.8 to 7.3 m/s) and high flow
velocity ratio relative to flow velocity in the adjacent aorta
( 3.5 in 10 RAs, between 2.5 and 3.5 in 14 RAs).
Renal arteriography was classic for FMD in only 8
patients. Among the remaining 12 patients, 7 had border-
line angiographic abnormalities, and 5 had normal arterio-
grams. In all patients, IVUS demonstrated endoluminal
abnormalities, including discrete, fixed, eccentric ridges;
fluttering membranes; and/or spiraling longitudinal folds.
These abnormalities were localized to those segments that
were abnormal on CFDI, but they were uniformly absent in
the proximal RA segments where CFDI indicated normal
Figure 1. (A) Classic “chain of beads” angiographic appearance. (B) Transverse view at the level of the origin of the right renal artery. There is laminar
flow in the proximal segment 1 cm (blue) beyond which flow is turbulent (multicolored mosaic pattern). (C) Intravascular ultrasound in the middle
segment of the right renal artery, demonstrating a membrane (arrow). Ao  aorta.
Table 1. Baseline Characteristics and SBP Measurements
Pt
Pre-PTA Post-PTA Follow-Up
Age Gender CM HTN DM Chol Tob SBP Meds SBP Meds SBP Meds Months
1 61 F Y Y Y Y 170 1 130 2 160 2 17
2 64 F Y Y Y 190 2 150 0 130 2 5
3 31 F Y Y 210 2 140 0
4 58 F Y Y 165 1 138 1 120 1 1
5 52 F Y Y 140 2 90 1 120 3 16
6 82 F Y Y 220 1 180 2 150 2 14
7 54 F Y Y 190 4 120 2 148 3 4
8 77 F Y Y 190 1 120 0
9 52 F Y Y 150 3 120 1 130 3 13
10 49 F Y 138 3 100 1 105 1 6
11 68 F Y Y Y Y 150 2 140 2 135 3 4
12 80 F Y Y 152 3 115 2 150 2 6
13 81 F Y Y Y 190 3 110 3 160 2 6
14 51 F Y Y 240 2 110 2 140 1 10
15 53 F Y Y 210 5 125 3 110 0 15
16 46 F Y 165 5 130 3 132 1 4
17 55 F Y Y 150 3 90 1 140 1 22
18 58 F Y Y 190 1 130 2
19 86 F Y 191 3 154 1
20 77 F Y Y 160 4 106 1
Chol cholesterol; CM cardiomyopathy; DM diabetes mellitus; HTN hypertension; Meds medicines; PTA percutaneous transluminal angioplasty; SBP systolic
blood pressure; Tob  tobacco use.
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flow patterns. In all patients whose angiograms demon-
strated the classic appearance of FMD, IVUS revealed these
surface abnormalities, and CFDI demonstrated deranged
blood flow patterns at the sites depicted angiographically
(Fig. 1). However, in all patients with borderline or normal
angiograms, IVUS identified qualitatively similar, and es-
sentially indistinguishable, defects at sites predicted by
CFDI (Figs. 2 and 3, respectively). In some patients whose
contralateral RAs were normal or borderline and whose
CFDI was normal, IVUS was performed and was uniformly
normal (Fig. 4A). A typical IVUS image demonstrating
discrete, fixed, eccentric ridges in a patient with FMD is
shown in Figure 4B.
After BA, the defects identified by IVUS were completely
eliminated in 16 patients and qualitatively improved in 4
(reduced number, length, and/or extension into the lumen).
Although not all patients were subjected to CFDI after
angioplasty, Figure 5 is an example of CFDI and flow
velocities before and after treatment. Overnight, during the
12- to 24-h period after angioplasty, systolic BPs fell into
the range of 90 to 180 mm Hg (mean 125  22 mm Hg).
The mean individual decrease in systolic pressure was 53
mm Hg (p  0.0001), with all patients having had a drop
of at least 30 mm Hg. After balloon angioplasty, the mean
number of antihypertensive medications was reduced to 1.8.
The antihypertensive medications were reduced in dose or
number or discontinued entirely before hospital discharge in
17 patients. In three patients, ACE inhibitors and/or
carvedilol were added because of diabetes and/or depressed
left ventricular function.
After hospital discharge and during follow-up office
visits, systolic BP remained in the range of 105 to 160 mm
Hg (mean 134  17 mm Hg). The mean individual
decrease in systolic pressure was 44 mm Hg (p  0.0001) at
a mean follow-up interval of 13 months (range 4 to 22
months) (Fig. 6). The mean number of antihypertensive
medications was reduced to 1.8.
DISCUSSION
About RA FMD. Renal artery stenosis is the most com-
mon cause of secondary hypertension and may be present in
up to 10% of patients presenting with hypertension (4). By
far, the most commonly reported etiology of RA stenosis is
atherosclerosis, accounting for greater than 90% of diag-
noses in most series. Atherosclerosis most commonly nar-
rows the RA at the ostium and/or within its proximal
segment. In contrast, FMD, representing the second most
common cause of RA stenosis, is detected at an earlier age,
affects women up to eight times more commonly than men,
and generally spares the proximal RA, typically being
localized in the middle and distal segments and occasionally
extending into primary branches (5). Most often, it occurs
in the absence of clinically apparent atherosclerosis, al-
though these two lesions can coexist in the same RA. Renal
artery FMD can also be accompanied by FMD in other
medium-to-large arteries, most notably the internal carotid
artery.
Harrison and McCormack (5) originally defined the
classification system for FMD according to the layer of the
arterial wall involved (intimal, medial, subadventitial fibro-
plasias, and fibromuscular hyperplasia). They noted that
most adults present with medial dysplasia, and it is the
dissection of this layer that leads to the complication and
development of narrowing in the arterial lumen, thus
predisposing to flow abnormalities. Histologically, medial
fibroplasia appears as areas of thinned media and thickened
fibromuscular ridges of collagen deposition without a lipid
Figure 2. (A) Right renal artery angiogram with subtle irregularities at the edges of the arterial lumen, producing a slightly scalloped appearance. (B)
Transverse view at the level of the origin of the right renal artery showing laminar flow in the proximal segment (red), becoming turbulent in the middle
segment, beginning with the first curve on the angiogram. (C) Intravascular ultrasound in the middle segment of the right renal artery, demonstrating a
membrane (arrow). Ao  aorta.
Figure 3. (A) Normal left renal arteriogram. (B) Transverse view at the level of the left renal artery with normal flow proximally (blue) and a narrowing
and turbulent flow (spiraling mosaic pattern) in the mid-portion. (C) Intravascular ultrasound demonstrating a membrane in the artery (arrow). Ao 
aorta.
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or inflammatory component. The internal elastic lamina is
nonexistent. Angiographically, the “string of beads” appear-
ance is seen (6). This classic appearance of FMD is the most
common form, representing 85% of all recognized cases (7).
These lesions are generally located in the distal two-thirds
of the main RA and sometimes extend into the branches.
The etiology of FMD is unknown (8,9).
Diagnosis of RA stenosis. Many screening tests are avail-
able for detecting RA stenosis, including measurement of
plasma renin activity (10), captopril-stimulated plasma re-
nin activity (11), nuclear renography (12), intravenous
pyelography (13), magnetic resonance angiography (14),
digital subtraction angiography (15), spiral computed tomo-
graphic (CT) imaging (16), and renal arteriography with
renal vein renin sampling (13). The reported sensitivities
and specificities range from 75% to 95%. In general,
however, these detection methods have been evaluated in
Figure 4. (A) Intravascular ultrasound (IVUS) of a normal renal artery. (B)
IVUS demonstrating discrete, fixed, eccentric ridge.
Figure 5. (A) Preangioplasty with abnormal color-flow duplex imaging (CFDI) and elevated flow velocity (200 cm/s). (B) Postangioplasty with
normalization of CFDI and flow velocity (84 cm/s).
Figure 6. Systolic blood pressure (BP) measurements: baseline, postangio-
plasty, outpatient follow-up.
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patients with atherosclerotic RA stenosis; they have not
been validated as screening tools for RA FMD. The “gold
standard” for the diagnosis of RA fibromuscular dysplasia is
the classically abnormal renal arteriogram or a pathologic
specimen (2).
Noninvasive imaging modalities available to identify
FMD include duplex ultrasonography, contrast-enhanced
magnetic resonance angiography (MRA), and spiral CT
angiography. Leung et al. (14) evaluated 60 patients using
duplex ultrasonography, contrast-enhanced MRA, and con-
ventional angiography for diagnosing renovascular disease
(including atherosclerosis and FMD). They reported 85% to
95% sensitivity and specificity in diagnosing RA stenosis
with duplex ultrasonography and contrast-enhanced MRA
versus angiography (“gold standard”). They noted that
MRA was similar to conventional angiography in providing
only an outline of the arterial lumen, which might not
adequately depict FMD. They postulated that future im-
provements in MRA and cross-sectional reconstruction
might be more helpful. Leung and colleagues also noted
that duplex ultrasonography was able to provide arterial flow
and hemodynamic information, which is not available with
MRA.
In another study by Beregi et al. (16), the role of helical
CT angiography was used to evaluate RA FMD. They
evaluated 20 patients with conventional and helical CT
angiography. Helical CT angiography using transverse sec-
tions and maximum-intensity projection reconstructions
identified RA FMD but was limited by the difficulty in
visualizing distal lesions. They concluded that conventional
angiography with pressure measurements should be the gold
standard to depict physiologically significant FMD.
Study implications. Our observations suggest that RA
FMD may be more common than traditional diagnostic
methodologies would suggest. The CFDI can indicate the
functional significance of an RA stenosis by measuring
blood flow velocity augmentation across the lesion (17).
Although customary measures of severity, such as percent
diameter stenosis, can, at least with atherosclerotic obstruc-
tion, be obtained more clearly with arteriography, it has
been shown that hydraulic assessment is a better predictor of
response to revascularization (16). Our findings further
show that CFDI can suggest that FMD is the cause of
renovascular hypertension by virtue of localizing flow dis-
turbance beyond the proximal RA segment and depicting
unusual flow patterns, most often spiraling, not usually seen
in atherosclerotic obstruction, although such patterns can
occur (in the proximal segment) with atherosclerosis in
complex lesions such as tandem stenoses or serpigenous
lumens. Finally, our observations call into question the
traditional regard for renal arteriography as the gold stan-
dard for diagnosing RA FMD. Whereas in patients with
classically abnormal arteriograms, CFDI and IVUS demon-
strate confirmatory findings, qualitatively similar ultrasound
observations can be made when angiography is borderline or
even normal. Moreover, the effects of BA on BP and on
IVUS abnormalities were, in this series of patients, inde-
pendent of the appearance of the baseline arteriogram.
The seeming failure of conventional angiography to
detect lumen surface abnormalities capable of detection with
IVUS and whose flow-disturbing effects can be demon-
strated with CFDI is not surprising. Though a space-
occupying atherosclerotic obstruction is generally well dem-
onstrated angiographically, very short, planar, cleft-like
lesions can escape angiographic detection in all but one
optimal view in which the cleft is parallel to the X-ray beam
(15). It perhaps should not be surprising that the occasion-
ally delicate, diaphanous, and membranous intimal folds so
clearly seen on IVUS can escape angiographic detection
when surrounded on both surfaces by contrast medium.
There are several limitations in these observations. The
number of patients is small and represents a single-center
experience. The series is defined by patients with CFDI
suggesting nonproximal RA obstruction with certain pat-
terns of flow derangement. The prevalence of similar IVUS
findings in normal patients (normal BP, no CFDI evidence
of RA stenosis of any type) or in patients with atheroscle-
rotic RA stenosis is unknown, although there were no such
findings in segments that appeared normal by CFDI and
angiography in this series. However, the consistent finding
of IVUS-depicted lumen surface abnormalities in locations
of substantial flow derangement demonstrated by CFDI,
coupled with their disappearance or reduction after BA,
which produced a uniform BP improvement, independent
of the renal arteriographic pattern, suggests that further
exploration in larger numbers of patients is warranted.
Conclusions. The diagnosis of RA FMD has traditionally
been made on the basis of a classic appearance on arteriog-
raphy. The findings of this study indicate that FMD can be
present when angiography is borderline or even normal. The
use of CFDI can demonstrate RA flow patterns suggestive
of FMD, and IVUS can depict the various luminal surface
abnormities representative of this disorder. These ultra-
sound imaging modalities correlate very closely with the BP
response to angioplasty. The findings call into question the
traditional regard for renal arteriography as the gold stan-
dard for diagnosing RA FMD, and they suggest that CFDI
and IVUS should be studied further in larger numbers of
patients and in multiple centers to define their role in the
diagnosis of this disorder.
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